Who Paid My Doc
Rapamune
Drug Inflammation;Transplant
NDC 0008-1030-06
General payments
$119
Research payments
$2,839,189
Through program year 2023, $119 in general payments and $2,839,189 in research payments were reported against Rapamune (Inflammation;Transplant).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $739,030 | 6 |
| 2022 | Research | $158,647 | 1 |
| 2021 | General | $119 | 6 |
| 2021 | Research | $142,955 | 2 |
| 2020 | Research | $498,152 | 9 |
| 2019 | Research | $1,300,405 | 7 |
Breakdown
The top 5 of 6 recipients; each share is of general payments naming this product in 2021.
Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2021 where a state was reported.
Records
6 general · 25 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.